The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Quidel's revenues will increase 64.9% and EPS will increase from $0.00 per share the prior year.
The average estimate for revenue is $62.6 million. On the bottom line, the average EPS estimate is $0.44.
Last quarter, Quidel chalked up revenue of $53.9 million. GAAP reported sales were 40% higher than the prior-year quarter's $38.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.37. GAAP EPS of $0.25 for Q4 were much higher than the prior-year quarter's $0.03 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 68.7%, much better than the prior-year quarter. Operating margin was 27.5%, much better than the prior-year quarter. Net margin was 16.2%, much better than the prior-year quarter.
The full year's average estimate for revenue is $184.9 million. The average EPS estimate is $0.70.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 165 members out of 173 rating the stock outperform, and eight members rating it underperform. Among 42 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 41 give Quidel a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Quidel is outperform, with an average price target of $19.75.
Is Quidel the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Quidel to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Quidel Corporation Is Sinking
News that a lawsuit is in the works has traders feeling uneasy.
Here's Why Quidel Corporation Stock Is Popping Today
Investors appear pleased with a recent revision to a deal with another point-of-care diagnostic developer.
Here's Why Quidel Corporation Is Rising Today
Traders cheer the news that the company is buying a handful of product lines from Alere.